A cost effectiveness analysis of solifenacin compared with extended-release tolterodine for the treatment of overactive bladder

被引：0
|
作者：
Kang, H. H. [1 ]
Bae, J. Y. [1 ]
Park, S. Y. [1 ]
Sohn, H. S. [1 ]
机构：
[1] Sock Myung Womens Univ, Seoul, South Korea
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65151-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A319 / A319
页数：1
相关论文
共 50 条
  • [1] Tolterodine extended-release for overactive bladder
    Chung, Doreen E.
    Te, Alexis E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2181 - 2194
  • [2] Update on tolterodine extended-release for treatment of overactive bladder
    Omotosho, Tola
    Chen, Chi Chiung Grace
    RESEARCH AND REPORTS IN UROLOGY, 2010, 2 : 185 - 191
  • [3] Cost-effectiveness analysis of extended-release tolterodine versus immediate-release tolterodine in the management of overactive bladder in spain
    Castro, D
    Soto, J
    Exposito, I
    VALUE IN HEALTH, 2004, 7 (06) : 798 - 798
  • [4] Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?
    Jean Jacques Wyndaele
    Nature Clinical Practice Urology, 2006, 3 : 184 - 185
  • [5] Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?
    Wyndaele, JJ
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (04): : 184 - 185
  • [6] Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom
    Samuel Aballéa
    Khaled Maman
    Katia Thokagevistk
    Jameel Nazir
    Isaac A. O. Odeyemi
    Zalmai Hakimi
    Andy Garnham
    Mondher Toumi
    Clinical Drug Investigation, 2015, 35 : 83 - 93
  • [7] Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom
    Aballea, Samuel
    Maman, Khaled
    Thokagevistk, Katia
    Nazir, Jameel
    Odeyemi, Isaac A. O.
    Hakimi, Zalmai
    Garnham, Andy
    Toumi, Mondher
    CLINICAL DRUG INVESTIGATION, 2015, 35 (02) : 83 - 93
  • [8] Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder
    Ginsberg, David
    Schneider, Tim
    Kelleher, Con
    Van Kerrebroeck, Philip
    Swift, Steven
    Creanga, Dana
    Martire, Diane L.
    BJU INTERNATIONAL, 2013, 112 (03) : 373 - 385
  • [9] Extended-release oxybutynin and tolterodine treat overactive bladder
    Ables, AZ
    JOURNAL OF FAMILY PRACTICE, 2003, 52 (11): : 829 - 830
  • [10] Extended-release tolterodine is an effective and convenient option in the treatment of overactive bladder
    不详
    Drugs & Therapy Perspectives, 2005, 21 (2) : 1 - 5
12345